The Femtech Market was valued at USD 60.2 billion in 2024, and is projected to reach USD 216.3 billion by 2034, rising at a CAGR of 16%. Femtech, short for female technology, focuses on developing innovative products, services, and platforms that address women’s unique healthcare needs. These include solutions for fertility, pregnancy, reproductive health, menopause, sexual wellness, and general well-being. Growing reliance on digital technologies to manage women’s health, especially in developed nations, has significantly propelled market growth.
Increasing chronic conditions such as cancer, diabetes, hypertension, and mental health issues among women are fueling the demand for personalized, tech-driven healthcare. Femtech offers tailored tools that assist women in managing complex health challenges, further boosting the market. The ongoing rise in awareness around women-centric health issues and the development of wearable and mobile health devices are driving the need for accessible and targeted solutions. The integration of advanced technology into everyday healthcare for women has encouraged more women to adopt digital platforms, creating strong market momentum.
In terms of type, the femtech market was estimated at USD 60.2 billion in 2024, with the product segment contributing USD 11.5 billion and expected to register a 13.8% growth rate from 2025 to 2034. Increasing demand for personalized healthcare solutions and rapid advancements in wearable devices and mobile health technologies are enhancing product adoption. Rising awareness about pregnancy complications and the need for innovative tools for monitoring and managing women’s health further support the market outlook. On the application front, femtech is divided into pregnancy and nursing care, reproductive health, pelvic and uterine healthcare, general healthcare and wellness, and others.
The reproductive health segment led the market with USD 26.4 billion in revenue in 2024, capturing a 43.9% share. Growing recognition of fertility, pregnancy, menstruation, and menopause-related health concerns, coupled with rising openness in discussing these issues, has increased demand for specialized reproductive health solutions. The incorporation of advanced wearable devices, mobile apps, and telemedicine has transformed reproductive health management, pushing the market forward.
Based on end use, the market is segmented into direct-to-consumer, hospitals, fertility clinics, surgical centers, diagnostic centers, and others. The direct-to-consumer segment accounted for USD 19.5 billion in 2024, driven by the rising preference for personalized healthcare tools accessible from home. Women are increasingly opting for products that address sensitive health needs while ensuring privacy and convenience. Femtech companies are also leveraging user data to create more effective and tailored solutions, boosting customer satisfaction and market penetration.
Regionally, North America generated USD 19.5 billion in revenue in 2024, with the U.S. accounting for 89.2% of this share, largely due to a growing focus on women’s health and increasing demand for accessible and affordable solutions.
This product will be delivered within 2-4 business days.
Increasing chronic conditions such as cancer, diabetes, hypertension, and mental health issues among women are fueling the demand for personalized, tech-driven healthcare. Femtech offers tailored tools that assist women in managing complex health challenges, further boosting the market. The ongoing rise in awareness around women-centric health issues and the development of wearable and mobile health devices are driving the need for accessible and targeted solutions. The integration of advanced technology into everyday healthcare for women has encouraged more women to adopt digital platforms, creating strong market momentum.
In terms of type, the femtech market was estimated at USD 60.2 billion in 2024, with the product segment contributing USD 11.5 billion and expected to register a 13.8% growth rate from 2025 to 2034. Increasing demand for personalized healthcare solutions and rapid advancements in wearable devices and mobile health technologies are enhancing product adoption. Rising awareness about pregnancy complications and the need for innovative tools for monitoring and managing women’s health further support the market outlook. On the application front, femtech is divided into pregnancy and nursing care, reproductive health, pelvic and uterine healthcare, general healthcare and wellness, and others.
The reproductive health segment led the market with USD 26.4 billion in revenue in 2024, capturing a 43.9% share. Growing recognition of fertility, pregnancy, menstruation, and menopause-related health concerns, coupled with rising openness in discussing these issues, has increased demand for specialized reproductive health solutions. The incorporation of advanced wearable devices, mobile apps, and telemedicine has transformed reproductive health management, pushing the market forward.
Based on end use, the market is segmented into direct-to-consumer, hospitals, fertility clinics, surgical centers, diagnostic centers, and others. The direct-to-consumer segment accounted for USD 19.5 billion in 2024, driven by the rising preference for personalized healthcare tools accessible from home. Women are increasingly opting for products that address sensitive health needs while ensuring privacy and convenience. Femtech companies are also leveraging user data to create more effective and tailored solutions, boosting customer satisfaction and market penetration.
Regionally, North America generated USD 19.5 billion in revenue in 2024, with the U.S. accounting for 89.2% of this share, largely due to a growing focus on women’s health and increasing demand for accessible and affordable solutions.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Type, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies featured in this Femtech market report include:- BioWink GmbH
- Athena Feminine Technologies
- Conceivable Inc.
- HeraMED
- Elvie
- iSono Health
- Nuvo Cares
- Minerva Surgical
- Prelude
- Sustain Natural
- Sera Prognostics
- Univfy
- Totohealth
